To assess the safety, reactogenicity and immunogenicity of GSK Biologicals' pneumococcal conjugate vaccine compared to Prevenarâ„¢, co-administered with DTPw-HBV/Hib % OPV or IPV vaccines as a 3-dose primary immunization course during the first 6 months of age
Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed)
Infections, Streptococcal
Phase 3
An annotated case report form is not available for this study. A blank case report form will be provided.
October 2014